Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Apalla, Z., & Lallas A. (2012).  Photoletter to the editor: Dermoscopy of atypical lichen sclerosus involving the tongue.. J Dermatol Case Rep. 6(2), 57-8.
Lallas, A., Apalla Z., Tzellos T., & Lefaki I. (2012).  Photoletter to the editor: Dermoscopy in clinically atypical psoriasis.. J Dermatol Case Rep. 6(2), 61-2.
Lallas, A., Apalla Z., Karteridou A., & Lefaki I. (2013).  Photoletter to the editor: Dermoscopy for discriminating between pityriasis rubra pilaris and psoriasis.. J Dermatol Case Rep. 7(1), 20-2.
Specchio, F., Argenziano G., Zalaudek I., Guardoli D., Longo C., Moscarella E., et al. (2014).  Photoletter to the editor: Collision tumor of melanoma and atypical fibroxanthoma of the scalp.. J Dermatol Case Rep. 8(3), 84-5.
Pathakoti, K., Morrow S., Han C., Pelaez M., He X., Dionysiou D. D., et al. (2013).  Photoinactivation of Escherichia coli by sulfur-doped and nitrogen-fluorine-codoped TiO2 nanoparticles under solar simulated light and visible light irradiation.. Environ Sci Technol. 47(17), 9988-96.
Sotiriou, E., Apalla Z., Chovarda E., Panagiotidou D., & Ioannides D. (2010).  Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up.. J Eur Acad Dermatol Venereol. 24(8), 916-20.
Sotiriou, E., Apalla Z., Vrani F., Lallas A., Chovarda E., & Ioannides D. (2015).  Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study.. J Eur Acad Dermatol Venereol. 29(2), 325-329.
Bakirtzi, K., Papadimitriou I., Vakirlis E., Lallas A., & Sotiriou E. (2023).  Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?. Dermatol Pract Concept. 13(4), 
Sotiriou, E., Koussidou-Eremonti T., Chaidemenos G., APALLA Z., & Ioannides D. (2010).  Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial.. Acta Derm Venereol. 90(2), 216-7.
Trakatelli, M., Charalampidis S., Novakovic L. B., Patsatsi A., Kalabalikis D., & Sotiriadis D. (2009).  Photodermatoses with onset in the elderly.. Br J Dermatol. 161 Suppl 3, 69-77.
Verrou, K-M., Galliou P. Angeliki, Papaioannou M., & Koliakos G. (2019).  Phosphorylation mapping of Laminin β1-chain: Kinases in association with active sites.. J Biosci. 44(2), 
Galliou, P. Angeliki, Verrou K-M., & Koliakos G. (2019).  Phosphorylation mapping of laminin α1-chain: Kinases in association with active sites.. Comput Biol Chem. 80, 480-497.
Pafili, Z., Maridaki M., Giannaki C. D., Karatzaferi C., Liakopoulos V., Eleftheriadis T., et al. (2019).  Phosphorus nutritional knowledge among dialysis health care providers and patients: A multicenter observational study.. Clin Nutr ESPEN. 31, 33-37.
Ioannides, D., Lazaridou E., Apalla Z., & Devliotou-Panagiotidou D. (2009).  Phosphodiesterase-5 inhibitors and rosacea: report of 10 cases.. Br J Dermatol. 160(3), 719-20.
Hatzimouratidis, K., & Hatzichristou D. G. (2009).  Phosphodiesterase type 5 inhibitors: unmet needs.. Curr Pharm Des. 15(30), 3476-85.
Hatzimouratidis, K., Burnett A. L., Hatzichristou D., McCullough A. R., Montorsi F., & Mulhall J. P. (2009).  Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.. Eur Urol. 55(2), 334-47.
Hatzimouratidis, K. (2009).  Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?. Expert Opin Investig Drugs. 18(3), 245-54.
Papa, A., Kontana A., & Tsergouli K. (2015).  Phlebovirus infections in Greece.. J Med Virol. 87(7), 1072-6.
Youssef, B., Pavlou G., & Tsiridis E. (2014).  Philadelphia 2013: international consensus meeting on periprosthetic joint infection.. Hip Int. 24(1), 3-4.
Chatzizisis, Y. S., Ziakas A., Feloukidis C., Paramythiotis D., Hadjimiltiades S., Iliadis A., et al. (2014).  Pheochromocytoma crisis presenting with cardiogenic shock.. Herz. 39(1), 156-60.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., & Harsoulis F. (2007).  Pheochromocytoma: an update on genetics and management.. Endocr Relat Cancer. 14(4), 935-56.
Boutou, A. K., Pitsiou G. G., Siakka P., Dimitroulas T., Paspala A., Sourla E., et al. (2016).  Phenotyping Exercise Limitation in Systemic Sclerosis: The Use of Cardiopulmonary Exercise Testing.. Respiration. 91(2), 115-23.
Abouzeid, H., Balmer A., Moulin A. P., Mataftsi A., Zografos L., & Munier F. L. (2012).  Phenotypic variability of retinocytomas: preregression and postregression growth patterns.. Br J Ophthalmol. 96(6), 884-9.
Hilgert, N., Huentelman M. J., Thorburn A. Q., Fransen E., Dieltjens N., Mueller-Malesinska M., et al. (2009).  Phenotypic variability of patients homozygous for the GJB2 mutation 35delG cannot be explained by the influence of one major modifier gene.. Eur J Hum Genet. 17(4), 517-24.
Papadimas, G. Konstantin, Kekou K., Papadopoulos C., Kararizou E., Kanavakis E., & Manta P. (2015).  Phenotypic variability and molecular genetics in proximal myotonic myopathy.. Muscle Nerve. 51(5), 686-91.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.